Cochlear Implant Atlas
CI Atlas · Candidacy & Evaluation · Module 16

16Cost-effectiveness, funding & access

Most of the people who would benefit from a cochlear implant never get one. That is not mainly a story of strict clinical criteria but of access: of the large population with severe-to-profound hearing loss, only a small fraction are ever referred, assessed and implanted. The leaks are at every stage — patients and even hearing-aid dispensers who do not know implantation exists or whom it serves, assessments done with the wrong materials, and a quiet under-referral that keeps eligible people out of the clinic. When funding is capped, a subtler distortion appears: financial pressure biases selection toward the 'most obvious' candidates and squeezes out borderline patients who would still gain. None of this is justified by the economics, which are strongly favourable. This module argues that widening access, not just refining criteria, is part of candidacy.

TThe under-referral gap

The gap is quantifiable. Tens of millions report significant hearing difficulty and a large number have severe-to-profound loss, yet historically only a small fraction — well under 10% of the eligible population — have ever been implanted. Candidacy, viewed honestly, is as much an access and referral problem as a clinical-criteria one.

From everyone who could benefit to the few implanted — and how funding squeezes it

Severe–profound, could benefit · 100%Aware / referred · 22%Formally assessed · 12%Implanted · 6%
Economic caseAdult CI ≈ $12,847 per QALY — favourable versus many accepted treatments; yet only a small fraction of eligible people are implanted.

Candidacy is also an access problem. Of the large severe-to-profound population who could benefit, only a small fraction — historically well under 10% — are ever implanted, lost at each step to low awareness, inappropriate pre-implant assessment, and under-referral. Capped funding then adds a rationing bias: financial pressure pushes selection toward the “most obvious” candidates and squeezes out borderline patients who would still gain, distorting selection away from clinical need. Yet the economics are strong — implantation is highly cost-effective per QALY — so widening access, not just tightening criteria, is part of candidacy. Figures illustrative. Schematic.

CWhy so few reach implantation

The named causes are mundane and fixable: lack of knowledge among hearing-aid consumers and dispensers about what implants do and whom they help; the use of inappropriate pre-implant assessment materials that fail to identify candidates; and low public awareness. Each is a leak in the funnel from “could benefit” to “implanted,” and each is addressable by education and better pathways rather than by changing the audiometric line.

CThe economic case

The economics strongly support implantation. Cost-utility analyses put adult cochlear implantation at roughly $12,847 per quality-adjusted life year — favourable against many accepted medical and surgical interventions — and paediatric implantation is cost-effective too, with downstream educational savings as more implanted children are mainstreamed.[2000][2004] Whatever the funding model, this cost-effectiveness must be estimated so that implantation competes fairly with other healthcare for resources.

CRationing bias

Capped funding introduces a “most obvious candidate” rationing bias: under financial pressure, selection drifts toward the patients expected to gain the most and quietly denies treatment to those expected to gain less — distorting candidacy away from clinical needand toward budget. Recognising this is important, because it means an apparently “objective” threshold can encode a funding constraint. The corrective is to keep candidacy a clinical judgement, fund it on its proven cost-effectiveness, and treat the access gap as a problem to be closed rather than a fact to be accepted.

Cost per QALY — implantation is well inside the accepted band

~$50k/QALY threshold~$12,847adult cochlear implant, cost per QALY$0k$20k$40k$60k

Candidacy decisions are made under budgets, so the economics matter. Adult cochlear implantation costs on the order of $12,847 per quality-adjusted life year — comfortably inside the commonly-cited ~$50,000/QALY band that society treats as good value, and favourable against many widely-accepted medical and surgical interventions. The point for candidacy: the implant is cost-effective, so the large gap between who could benefit and who is implanted is an access failure, not an economic verdict. Illustrative figures; schematic.

Case 11.16 · The funnel and the cap
An audit finds that only a small fraction of eligible severe-to-profound patients in a region are implanted, and that under a tight budget only the 'most obvious' candidates proceed.

How should this be interpreted?

Self-assessment — Module 162 questions
Question 1 · Trainee

What does the large gap between eligible and implanted patients mainly reflect?

Question 2 · Clinician

What is the 'most obvious candidate' rationing bias?

Tracked locally in your browser — see /progress for the dashboard.